Phase III monarchE trial of Verzenio in breast cancer published in Annals of Oncology – Eli Lilly
Eli Lilly announced updated data from the positive Phase III monarchE trial evaluating the investigational use of Verzenio (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) for… read more.
